United Therapeutics Gets FDA Clearance to Begin Trial of Inhaled PAH Therapy
The FDA cleared the company to begin clinical testing of Treprostinil-Iloprost SMI, an investigational inhaled combination therapy for pulmonary arterial hypertension.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.